Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BDMDNASDAQ:BSGMNASDAQ:DXRNASDAQ:INBS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBDMDBaird Medical Investment$5.22-2.4%$5.38$1.05▼$12.50$34.37M-0.74445,987 shs20,240 shsBSGMBioSig Technologies$1.80+22.7%$0.76$0.20▼$2.57$35.65M0.02243,032 shs756,101 shsDXRDaxor$7.70+3.1%$7.80$6.55▼$10.00$37.25M-0.216,666 shs3,178 shsINBSIntelligent Bio Solutions$1.20+4.8%$1.57$1.00▼$3.00$8.17M4.63547,565 shs87,402 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBDMDBaird Medical Investment0.00%-6.96%-4.80%-10.54%+534,999,900.00%BSGMBioSig Technologies+1.73%+42.72%+177.36%+58.23%+10.53%DXRDaxor-1.32%+1.22%+0.27%-4.35%-23.78%INBSIntelligent Bio Solutions-4.58%-10.55%-13.26%-41.28%-60.38%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBDMDBaird Medical InvestmentN/AN/AN/AN/AN/AN/AN/AN/ABSGMBioSig Technologies1.8607 of 5 stars3.50.00.00.02.40.80.6DXRDaxor3.553 of 5 stars3.54.00.00.00.63.30.0INBSIntelligent Bio Solutions0.1083 of 5 stars0.02.00.00.00.60.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBDMDBaird Medical Investment 0.00N/AN/AN/ABSGMBioSig Technologies 3.00Buy$2.5038.66% UpsideDXRDaxor 3.00Buy$25.00224.68% UpsideINBSIntelligent Bio Solutions 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest INBS, BDMD, BSGM, and DXR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/21/2025BSGMBioSig TechnologiesAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$2.75 ➝ $2.503/17/2025DXRDaxorAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$24.75 ➝ $25.00(Data available from 5/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBDMDBaird Medical Investment$33.05M1.04N/AN/AN/A∞BSGMBioSig Technologies$40K1,093.16N/AN/A($0.33) per share-5.46DXRDaxor$2.13M17.48N/AN/AN/A∞INBSIntelligent Bio Solutions$3.03M2.70N/AN/A$0.80 per share1.50Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBDMDBaird Medical InvestmentN/AN/A0.00∞N/AN/AN/AN/AN/ABSGMBioSig Technologies-$29.04MN/A0.00N/AN/A-44,832.50%N/A-776.49%5/19/2025 (Estimated)DXRDaxorN/AN/A0.00∞N/AN/AN/AN/AN/AINBSIntelligent Bio Solutions-$10.16MN/A0.003.43N/A-323.79%-146.03%-83.62%5/14/2025 (Estimated)Latest INBS, BDMD, BSGM, and DXR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/19/2025N/ABSGMBioSig Technologies-$0.18N/AN/AN/AN/AN/A2/13/2025Q2 2025INBSIntelligent Bio SolutionsN/A-$0.50N/A-$0.50N/A$610.00 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBDMDBaird Medical InvestmentN/AN/AN/AN/AN/ABSGMBioSig TechnologiesN/AN/AN/AN/AN/ADXRDaxor$0.030.39%N/AN/AN/AINBSIntelligent Bio SolutionsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBDMDBaird Medical InvestmentN/AN/AN/ABSGMBioSig TechnologiesN/A0.500.50DXRDaxorN/AN/AN/AINBSIntelligent Bio SolutionsN/A0.920.76Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBDMDBaird Medical Investment19.78%BSGMBioSig Technologies7.16%DXRDaxor1.34%INBSIntelligent Bio Solutions32.97%Insider OwnershipCompanyInsider OwnershipBDMDBaird Medical Investment78.90%BSGMBioSig Technologies17.03%DXRDaxor59.00%INBSIntelligent Bio Solutions1.54%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBDMDBaird Medical InvestmentN/A6.58 million1.39 millionN/ABSGMBioSig Technologies5024.25 million14.30 millionNo DataDXRDaxor374.84 million1.98 millionNot OptionableINBSIntelligent Bio Solutions106.81 million5.26 millionNot OptionableINBS, BDMD, BSGM, and DXR HeadlinesRecent News About These CompaniesIntelligent Bio Solutions Drives Global Growth Through Multilingual Digital ExpansionMay 6 at 8:30 AM | globenewswire.comINBS Intelligent Bio Solutions Inc.April 25, 2025 | seekingalpha.comIntelligent Bio Solutions Adds Latin American Spanish To Drug Screening System To Expand ReachApril 24, 2025 | nasdaq.comIntelligent Bio Solutions integrates Latin American Spanish into IFDSSApril 23, 2025 | markets.businessinsider.comIntelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening SystemApril 22, 2025 | globenewswire.comIntelligent Bio integrate Arabic as 2nd international language to IFDS systemMarch 31, 2025 | markets.businessinsider.comIntelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening SystemMarch 31, 2025 | globenewswire.comIntelligent Bio Solutions to highlight drug testing tech at 2025 NDASAMarch 28, 2025 | markets.businessinsider.comIntelligent Bio Solutions, Inc.: Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and AndorraMarch 28, 2025 | finanznachrichten.deIntelligent Bio Solutions to Highlight Proprietary Drug Testing Technology at 2025 NDASA Conference and Trade ShowMarch 28, 2025 | globenewswire.comIntelligent Bio Solutions announces strategic partnership in Spain, AndorraMarch 28, 2025 | markets.businessinsider.comIntelligent Bio Solutions Stock Drops Despite Key U.S. Patent WinMarch 27, 2025 | zacks.comIntelligent Bio Solutions, Inc.: Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market EntryMarch 27, 2025 | finanznachrichten.deUS patent granted for INBS’ fingerprint drug screening technologyMarch 27, 2025 | medicaldevice-network.comIntelligent Bio Solutions secures U.S. patent, strengthening IP protectionMarch 27, 2025 | markets.businessinsider.comIntelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and AndorraMarch 27, 2025 | globenewswire.comEXCLUSIVE: Intelligent Bio Solutions Adds Sixth US Patent For Its Drug Screening TechnologyMarch 26, 2025 | benzinga.comIntelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market EntryMarch 26, 2025 | globenewswire.comIntelligent Bio Solutions’ FDA Clearance Process Remains on Track for 2025 U.S. LaunchMarch 25, 2025 | markets.businessinsider.comIntelligent Bio Solutions' FDA Clearance Process Remains on Track for 2025 U.S. LaunchMarch 25, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeINBS, BDMD, BSGM, and DXR Company DescriptionsBaird Medical Investment NASDAQ:BDMD$5.22 -0.13 (-2.43%) As of 03:51 PM EasternBaird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.BioSig Technologies NASDAQ:BSGM$1.80 +0.33 (+22.65%) Closing price 03:59 PM EasternExtended Trading$2.08 +0.27 (+15.14%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.Daxor NASDAQ:DXR$7.70 +0.23 (+3.08%) As of 03:25 PM EasternDaxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.Intelligent Bio Solutions NASDAQ:INBS$1.20 +0.06 (+4.80%) Closing price 04:00 PM EasternExtended Trading$1.25 +0.05 (+3.75%) As of 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Is Energy Transfer Undervalued or a Value Trap? Carvana’s Stock Price Rebound Shifts Into a Higher Gear Why Investors Should Be Careful About AMC's Bitcoin Dreams Alphabet Slumps as Apple Eyes AI Search—Is the Sell-Off Overdone? Joby's Q1: Key Milestones Achieved as Path to Market Crystalizes Rockwell Automation: Tailwinds From Onshoring U.S. Production IBM's AI Offensive: Assessing IBM's Path to Renewed Growth Upwork's Earnings Beat Fuels Stock Rally—Is Freelancing Booming? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
